BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 6761860)

  • 1. Captopril in treatment-resistant essential and renal hypertension.
    Aurell M; Delin K; Herlitz H
    Scand J Urol Nephrol; 1982; 16(3):243-9. PubMed ID: 6761860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Participation of the renin system in treatment-resistant hypertension as measured by acute blockade of the angiotensin converting enzyme.
    Weber MA; Drayer JI; Priest RT; Chen TC
    Am J Nephrol; 1982; 2(1):6-11. PubMed ID: 6295161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Captopril, an orally active angiotensin I converting enzyme inhibitor in the treatment of renovascular and essential hypertension.
    Holtzman E; Rosenthal T; Stern N; Knecht A; Yaron A
    Isr J Med Sci; 1982 May; 18(5):597-602. PubMed ID: 6284678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute and chronic effects of the angiotensin-converting enzyme inhibitor captopril in severe hypertension.
    Havelka J; Vetter H; Studer A; Greminger P; Lüscher T; Wollnik S; Siegenthaler W; Vetter W
    Am J Cardiol; 1982 Apr; 49(6):1467-74. PubMed ID: 6280477
    [No Abstract]   [Full Text] [Related]  

  • 5. The antihypertensive effect of captopril in severe essential, renovascular, renal and transplant renovascular hypertension.
    Schwietzer G; Oelkers W
    Klin Wochenschr; 1982 Aug; 60(16):839-46. PubMed ID: 6752559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Inhibition of the angiotensin I converting enzyme with SQ-14225 (captopril) in the medical treatment of severe renovascular hypertension].
    Martínez Amenós A; Caralps A; Rama H; Sarrias X; Alsina J
    Rev Clin Esp; 1981 Sep; 162(6):265-8. PubMed ID: 7036249
    [No Abstract]   [Full Text] [Related]  

  • 7. Long-term efficacy of captopril in renovascular and essential hypertension.
    Case DB; Atlas SA; Marion RM; Laragh JH
    Am J Cardiol; 1982 Apr; 49(6):1440-6. PubMed ID: 6803561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the hormonal and renal effects of captopril in severe essential and renovascular hypertension.
    Aldigier JC; Plouin PF; Guyene TT; Thibonnier M; Corvol P; Menard J
    Am J Cardiol; 1982 Apr; 49(6):1447-52. PubMed ID: 7041584
    [No Abstract]   [Full Text] [Related]  

  • 9. Active and inactive renin after a single dose of captopril in hypertensive patients.
    Glorioso N; Dessi Fulgheri P; Madeddu P; Fois G; Palermo M; Cocco F; Dettori S; Rappelli A
    Am J Cardiol; 1982 Apr; 49(6):1552-4. PubMed ID: 7041596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antihypertensive effects of captopril and saralasin in essential and renal hypertension.
    Konrads A; Meurer KA; Hummerich W; Wambach G; Kindler J; Feltkamp H; Helber A
    Am J Cardiol; 1982 Apr; 49(6):1558-60. PubMed ID: 7041597
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of 12-hour infusions of saralasin or captopril on blood pressure in hypertensive conscious rats. Relationship to plasma renin, duration of hypertension, and effect of unclipping.
    Bing RF; Russell GI; Swales JD; Thurston H
    J Lab Clin Med; 1981 Aug; 98(2):302-10. PubMed ID: 7019368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemodynamic effects of captopril in essential hypertension, renovascular hypertension and cardiac failure: correlations with short- and long-term effects on plasma renin.
    Wenting GJ; de Bruyn JH; Man in't Veld AJ; Woittiez AJ; Derkx FH; Schalekamp MA
    Am J Cardiol; 1982 Apr; 49(6):1453-9. PubMed ID: 6803562
    [No Abstract]   [Full Text] [Related]  

  • 13. [Use of captopril in arterial hypertension with a stable and malignant course].
    Lordkipanidze NL
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1984; 7(1):111-7. PubMed ID: 6145432
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of captopril on renal function in hypertensive patients.
    Pessina AC; Semplicini A; Rossi G; Gatta A; Palatini P; Gava R; Casiglia E; Dal Palú C
    Am J Cardiol; 1982 Apr; 49(6):1572-3. PubMed ID: 7041601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Captopril for refractory hypertension in patients with impaired renal function.
    Laher MS; O'Regan P; O'Donohoe JF; Counihan TB
    J R Soc Med; 1985 May; 78(5):367-72. PubMed ID: 3886905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Captopril in the management of hypertension with renal artery stenosis: its long-term effect as a predictor of surgical outcome.
    Atkinson AB; Brown JJ; Cumming AM; Fraser R; Lever AF; Leckie BJ; Morton JJ; Robertson JI; Davies DL
    Am J Cardiol; 1982 Apr; 49(6):1460-6. PubMed ID: 7041585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increase in plasma aldosterone during prolonged captopril treatment.
    Lijnen P; Staessen J; Fagard R; Amery A
    Am J Cardiol; 1982 Apr; 49(6):1561-3. PubMed ID: 7041598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of captopril on renal hemodynamics in the treatment of resistant renal hypertension.
    Björck S; Herlitz H; Nyberg G; Granerus G; Aurell M
    Hypertension; 1983; 5(5 Pt 2):III152-3. PubMed ID: 6354931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Captopril treatment in hypertensive dialysis patients.
    Aurell M; Delin K; Herlitz H; Mulec H
    Scand J Urol Nephrol; 1982; 16(3):251-6. PubMed ID: 6761861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Captopril in the treatment of refractory high-renin hypertension.
    Cutfield R; Sharpe DN; Clarke ED
    N Z Med J; 1980 Jun; 91(661):424-6. PubMed ID: 6104314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.